In methotrexate resistant rheumatoid arthritis, switching methotrexate to tofacitinib versus adding tofacitinib to methotrexate, open labeled, multicenter randomized non-inferiority study.
Phase of Trial: Phase IV
Latest Information Update: 10 May 2017
At a glance
- Drugs Tofacitinib (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms RAXEL
- 08 May 2017 Planned End Date changed from 18 May 2017 to 18 May 2019.
- 14 May 2016 Planned End Date changed from 18 Jun 2015 to 18 May 2017.
- 13 Nov 2015 Status changed from not yet recruiting to recruiting, as reported by University Hospital Medical Information Network - Japan record.